The historical rank and industry rank for ATAI Life Sciences NV's Net Margin % or its related term are showing as below:
ATAI'
s Net Margin % Range Over the Past 10 Years
Min: -65401.29 Med: -12810.19 Max: -823.56
Current: -38852.87
ATAI's Net Margin % is ranked worse than 95.85% of 1013
companies
in the Biotechnology industry
Industry Median: -140.3
vs ATAI: -38852.87
ATAI Life Sciences NV Net Margin % Historical Data
The historical data trend for ATAI Life Sciences NV's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ATAI Life Sciences NV's Net Margin %
For the Biotechnology subindustry, ATAI Life Sciences NV's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ATAI Life Sciences NV's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's Net Margin % distribution charts can be found below:
* The bar in red indicates where ATAI Life Sciences NV's Net Margin % falls into.
ATAI Life Sciences NV Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
ATAI Life Sciences NV's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATAI Life Sciences NV (NAS:ATAI) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
ATAI Life Sciences NV Net Margin % Related Terms
Thank you for viewing the detailed overview of ATAI Life Sciences NV's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATAI has been successfully added to your 